Determination of a novel cognitive enhancer, X9121, and its mono N-oxide metabolite, XG696, in dog plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-03-10
著者
-
Lee William
Drug Metabolism And Pharmacokinetics Section Stine-haskell Research Center The Dupont Merck Pharmace
-
Holm Karsten
Drug Metabolism And Pharmacokinetics Section Stine-haskell Research Center The Dupont Merck Pharmace
-
KAPIL Ram
Drug Metabolism and Pharmacokinetics Section, Stine-Haskell Research Center, The DuPont Merck Pharma
-
PADOVANI Patricia
Drug Metabolism and Pharmacokinetics Section, Stine-Haskell Research Center, The DuPont Merck Pharma
-
WONG Nancy
Drug Metabolism and Pharmacokinetics Section, Stine-Haskell Research Center, The DuPont Merck Pharma
-
LAM Gilbert
Drug Metabolism and Pharmacokinetics Section, Stine-Haskell Research Center, The DuPont Merck Pharma
-
Kapil Ram
Drug Metabolism And Pharmacokinetics Section Stine-haskell Research Center The Dupont Merck Pharmace
-
Wong Nancy
Drug Metabolism And Pharmacokinetics Section Stine-haskell Research Center The Dupont Merck Pharmace
-
Lam Gilbert
Drug Metabolism And Pharmacokinetics Section Stine-haskell Research Center The Dupont Merck Pharmace
-
Padovani Patricia
Drug Metabolism And Pharmacokinetics Section Stine-haskell Research Center The Dupont Merck Pharmace
関連論文
- Determination of a novel cognitive enhancer, X9121, and its mono N-oxide metabolite, XG696, in dog plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection
- Determination of brequinar in rat plasma by direct deproteinization and reversed-phase high-performance liquid chromatography with ultraviolet absorbance detection